CME Group Inc.
NASDAQCME Group heads into its July 22 earnings with an interesting split: a fresh analyst upgrade sitting against a stock that has shed 12% in a month, with options positioning quietly turning more constructive. The analyst angle is the standout this week. Rothschild & Co upgraded CME to Buy on June 11, lifting its target from $316 to $323 — a rare directional shift against a backdrop…
CME cost to borrow jumps 106% over the past week to 0.48%, rebounding sharply from a low of 0.23% on April 15th.
Snapshot as of 22 Jun 2026
CME Group heads into its July 22 earnings with an interesting split: a fresh analyst upgrade sitting against a stock that has shed 12% in a month, with options positioning quietly turning more constructive. The analyst…
CME Group reports its Q2 results on June 9 against a backdrop of genuine tension: the stock has shed 10% over the past month to $257.40, yet options traders are the most bullish on the name they've been all year. The…
CME Group heads into its May 14 Q1 results with the stock under pressure, analyst targets moving in conflicting directions, and valuation multiples in a quiet decline. The most telling signal this week is in analyst…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CME — free to start on ORTEX.
Sign up for free →Open CME on ORTEX